At the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen trimethobenzamide hydrochloride, 250 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic
This is the 2012 version of HCPCS Q0173 - please refer to the 2016 HCPCS code set for the latest version.
